Results 101 to 110 of about 49,570 (218)
Emerging pharmacological treatments to prevent abdominal aortic aneurysm growth and rupture [PDF]
, 2015 Abdominal aortic aneurysm (AAA) is a local expansion of the abdominal aorta wall caused by a complex multifactorial maladaptive vascular remodeling. Despite recent advances in the management of cardiovascular diseases, there currently is no established ...
Fraga-Silva, Rodrigo +2 more
core +2 more sources
DEN Open, Volume 6, Issue 1, April 2026.Abstract We report an uncommon case of perforated peritonitis resulting from the migration of a single‐puncture gastric wall fixation device following percutaneous endoscopic gastrostomy. An 83‐year‐old male developed acute peritonitis 6 days post‐procedure, requiring emergency surgery.
Yuu Kodama +8 more
wiley +1 more source
Bridging Clinical Knowledge and AI Interpretability in Thoracic Radiology
iRADIOLOGY, EarlyView.
Mengze Xu
wiley +1 more source
Embedding Pharmacogenetics Into Clinical Practice to Improve Patient Outcomes
Annals of Human Genetics, Volume 89, Issue 5, Page 398-405, September 2025.ABSTRACT Pharmacogenomics, the use of germline genomic data to guide prescription to improve effective and safer medication, holds promise as a clinical intervention. To date in most health systems, there has been limited uptake of pharmacogenomic testing confined to a few single drug–gene associations.
John Henry McDermott +3 more
wiley +1 more source
Endovascular repair of thoracic aortic aneurysm
Archives of Medical Science, 2010 A thoracic aortic aneurysm (TAA) is a potentially life-threatening condition with structural weakness of the aortic wall, which can progress to arterial dilatation and rupture. Today, both an increasing awareness of vascular disease and the access to tomographic imaging facilitate the diagnosis of TAA even in an asymptomatic stage.
Hüseyin Ince +5 more
openaire +3 more sources
ACR Open Rheumatology, Volume 7, Issue 8, August 2025.Giant cell arteritis (GCA) is a granulomatous vasculitis that can involve both cranial and extracranial vessels. Although interleukin‐6 (IL‐6) receptor blockade is an established therapy, treatment options for medically refractory disease remain limited.
Luke S. Vest +4 more
wiley +1 more source
Treatment of a rapidly expanding thoracoabdominal aortic aneurysm after endovascular repair of descending thoracic aortic aneurysm in an old patient. [PDF]
, 2012 Background: Aortic pathology progression and/or procedure related complications following endovascular repair should always be considered mostly in older patients.
A. D’Alessio +7 more
core +2 more sources
Clinical Case Reports, Volume 13, Issue 8, August 2025.ABSTRACT Platypnea‐orthodeoxia syndrome is a rare disorder characterized by dyspnea (platypnea) and arterial desaturation (orthodeoxia) in the upright position, with symptom relief upon lying down. This syndrome is commonly associated with cardiac anomalies, particularly patent foramen ovale (PFO), where increased right atrial pressure facilitates ...
Cristian Castillo‐Rodriguez +7 more
wiley +1 more source
Successful emergency endovascular treatment of juxtarenal and infrarental mycotic aortic aneurysms in patients with small diameter aortae using Cook® Zenith ESLE stentgrafts [PDF]
, 2012 BACKGROUND: Endovascular repair of mycotic aneurysm is an alternative to open repair if the patho-anatomy is suitable. The aortic size above and below the mycotic aneurysm may be small.
Chan, YC, Cheng, SWK, Ting, ACW, Yiu, WK
core +1 more source
ESC Heart Failure, Volume 12, Issue 4, Page 2749-2758, August 2025.Abstract Aims Cardiopulmonary bypass (CPB) is the standard approach for coronary artery bypass grafting (CABG) in advanced ischaemic cardiomyopathy. Microaxial pump support has been envisioned to allow for beating‐heart CABG without CPB (MPCAB), thereby avoiding CPB‐inherent complications.
Anna Kathrin Assmann +5 more
wiley +1 more source